suhao

海问律师事务所近日迎来跨境并购、私募股权投资专家苏浩律师以合伙人身份加盟,他将执业于北京和香港办公室。此前,苏律师在美国摩根路易斯律师事务所驻北京办事处担任合伙人。

苏律师专注于复杂跨境并购﹑项目开发和融资、合资企业法律事宜,行业涉及先进制造业、能源与自然资源、科技、医药、物流、消费品、媒体、金融服务和不动产,区域包括欧洲、亚太、中东、非洲、北美和拉丁美洲。苏律师在私募股权投资、中国境内并购等方面亦有经验。

这是海问继今年4月迎来贾媛媛律师后的最新一起合伙人级别引入。

Haiwen bolsters M&A practice by adding ex-Morgan Lewis partner

Chinese firm Haiwen & Partners has recently hired Su Hao, an expert in cross-border M&A and private equity investment, as a partner who will work in its Beijing and Hong Kong offices. Prior to joining Haiwen, Su was a partner at U.S. firm Morgan, Lewis & Bockius.

Su focuses on complex cross-border M&A, project development and finance, and joint venture, involving a range of industries including advanced manufacturing, energy, technology, medicine, logistics, consuming, media, financial services, and real estate. He covers Europe, Asia Pacific, Middle East, Africa, and North and Latin America. Su also has experience in private equity investment and China domestic M&A.

This is Haiwen’s latest partner level hire since adding Jia Yuanyuan in April.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

海问迎两位专家加盟北京、深圳办公室(ZH/EN)

by Charlie Wu 吴卓言 |

海问律师事务所近日迎来两位专家李方正、姜迎宁律师以合伙人身份加入其北京、深圳办公室。

环球、海问等牵头老铺黄金9.06亿港元香港上市(ZH/EN)

中国黄金品牌老铺黄金在港交所主板成功上市。环球律师事务所、美迈斯律师事务所作为公司律师参与交易;海问律师事务所、年利达律师事务所则为保荐人中信建投提供服务。

海问、高伟绅领衔中国中药年内最大私有化交易(ZH/EN)

国药集团共裕有限公司、中国中药控股有限公司近期发布公告,将以计划安排的方式私有化中国中药,并拟在私有化要约完成后撤销中国中药的港交所上市地位,该交易总额约为港币156亿元。